Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: Journal of Medical Internet Research

Date Submitted: Dec 23, 2021
Date Accepted: Feb 4, 2022

The final, peer-reviewed published version of this preprint can be found here:

Indicated Web-Based Prevention for Women With Anorexia Nervosa Symptoms: Randomized Controlled Efficacy Trial

Jacobi C, Vollert B, Hütter K, von Bloh P, Eiterich N, Görlich D, Taylor CB

Indicated Web-Based Prevention for Women With Anorexia Nervosa Symptoms: Randomized Controlled Efficacy Trial

J Med Internet Res 2022;24(6):e35947

DOI: 10.2196/35947

PMID: 35653174

PMCID: 9204567

Indicated, Web-based Prevention for Women With Anorexia Nervosa Symptoms: A Randomised Controlled Efficacy Trial

  • Corinna Jacobi; 
  • Bianka Vollert; 
  • Kristian Hütter; 
  • Paula von Bloh; 
  • Nadine Eiterich; 
  • Dennis Görlich; 
  • Craig Barr Taylor

ABSTRACT

Background:

While preventive interventions for eating disorders in general have shown promise, interventions specifically targeting individuals at risk for anorexia nervosa have not been evaluated.

Objective:

To determine the efficacy of a guided, indicated, Internet-based prevention program for women at risk for anorexia nervosa (AN).

Methods:

Randomized, controlled efficacy trial for women at risk for AN. Assessments at baseline (pre), post-intervention (10 weeks after baseline), 6-, and 12-month follow-up (FU). 168 women with low body weight (17.5≤BMI≤19) and high weight concerns, or with normal body weight 19

Results:

Data were available at post-intervention for N=137 women, and for N=116 women at 12-month FU. At 12-month FU, IGs participants showed larger decreases in EDE Total scores (79% vs. 57%) compared to the CG, and underweight IG participants also showed larger clinically relevant increases in BMI (49% vs. 32%) compared with underweight CG participants, but these differences were not significant. In addition, at post-intervention and 12-month follow-up, we found a significant increase in continuously measured BMI for underweight participants and significant improvements in attitudes and behaviours of disordered eating (e.g., restrained eating, weight and shape concerns). At all time points, rates of newly emerging ED onset cases were (non-significantly) lower in the IG compared with the CG and reductions in DSM-5-based ED syndromes were (non-significantly) higher in the IG compared with the CG.

Conclusions:

SB-AN is the first preventive intervention shown to significantly reduce specific risk factors and symptoms for AN and shows promise for reducing full-syndrome AN onset. Clinical Trial: ISRCTN70380261


 Citation

Please cite as:

Jacobi C, Vollert B, Hütter K, von Bloh P, Eiterich N, Görlich D, Taylor CB

Indicated Web-Based Prevention for Women With Anorexia Nervosa Symptoms: Randomized Controlled Efficacy Trial

J Med Internet Res 2022;24(6):e35947

DOI: 10.2196/35947

PMID: 35653174

PMCID: 9204567

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.